Interventional Cardiology Devices | Europe | 2018 | Market Analysis

The European IC device market will experience gradual contraction throughout the first half of the forecast period, primarily as a result of declining public health care expenditure, pricing pressures, and high competition in this space. Nevertheless, emerging technologies will continue to be adopted, and this will remain a large and lucrative market for manufacturers. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for IC devices in Europe across a 10-year period.​

Continuing innovation in coronary stent technology will be a primary driver of the European IC market, despite setbacks with BVS and immense pricing pressure.

How will current-generation DES shape the European coronary stent market over the forecast period?

What is the outlook of the BVS segment following the withdrawal of Absorb?

Will the the continued dominance of DES drive BMS to obscurity?

What are the emerging technologies and competitors in the coronary stent market?

Variable ASP trends will play a significant role in determining market growth over the forecast period.

How will ASP trends vary by country?

What are the effects of government-driven pricing pressure on ASPs, and which product segments will be most impacted?

What tactics are competitors using to mitigate pricing pressures?

Despite contraction of the overall market, some segments present opportunities for revenue growth.

How are competitors responding to increasing price pressures? 

What strategies are competitors implementing to capture share in these growing market?